0,982  0,001  UGT1A9 substrate
0,978  0,002  Chemoprotective
0,974  0,001  Antimutagenic
0,974  0,002  Genotoxic
0,969  0,002  Monophenol monooxygenase inhibitor
0,963  0,004  Alpha-glucosidase inhibitor
0,954  0,002  Chemopreventive
0,949  0,001  UGT1A1 substrate
0,943  0,001  Cystathionine beta-synthase inhibitor
0,942  0,003  TNF expression inhibitor
0,936  0,001  Xanthine oxidase inhibitor
0,937  0,003  Antioxidant
0,935  0,003  Mutagenic
0,928  0,002  Proliferative diseases treatment
0,926  0,002  NOS2 expression inhibitor
0,914  0,002  Sulfotransferase substrate
0,913  0,003  Antihypercholesterolemic
0,911  0,003  UDP-glucuronosyltransferase substrate
0,904  0,002  Antihypoxic
0,904  0,003  Free radical scavenger
0,903  0,003  Caspase 9 stimulant
0,899  0,001  Antihemorrhagic
0,899  0,003  Cardioprotectant
0,901  0,006  Transcription factor NF kappa B inhibitor
0,895  0,004  Carcinogenic
0,882  0,003  Histamine release inhibitor
0,875  0,003  UGT1A6 substrate
0,870  0,004  Radioprotector
0,868  0,008  Antiinflammatory
0,861  0,004  Cytostatic
0,858  0,005  CYP2C9 substrate
0,848  0,001  Amylase inhibitor
0,853  0,010  Apoptosis agonist
0,834  0,005  Cyclophilin D inhibitor
0,834  0,005  Antidiabetic
0,824  0,003  Vasodilator, coronary
0,805  0,004  Angiogenesis stimulant
0,802  0,002  Carbonic anhydrase XIII inhibitor
0,800  0,004  Vascular (periferal) disease treatment
0,791  0,002  Beta glucuronidase inhibitor
0,793  0,004  Hypoglycemic
0,788  0,004  NOS3 expression inhibitor
0,783  0,002  Melanin inhibitor
0,773  0,005  Antithrombotic
0,770  0,003  Antihypotensive
0,752  0,004  AR expression inhibitor
0,752  0,005  Antibacterial
0,750  0,012  Teratogen
0,737  0,004  Antihypertriglyceridemic
0,735  0,005  Nitric oxide antagonist
0,731  0,005  Spasmolytic
0,729  0,009  Respiratory analeptic
0,724  0,005  Hepatic disorders treatment
0,720  0,004  Ulceration
0,732  0,015  CYP3A4 substrate
0,709  0,004  Skin whitener
0,708  0,003  NADPH oxidase inhibitor
0,708  0,005  Antiamyloidogenic
0,698  0,004  Hepatoprotectant
0,694  0,003  NOS3 expression enhancer
0,693  0,007  CTGF expression inhibitor
0,689  0,005  Hypoxia-inducible factor 1 alpha inhibitor
0,698  0,015  Embryotoxic
0,684  0,006  Antiparasitic
0,674  0,005  5 Hydroxytryptamine release inhibitor
0,672  0,005  Apoptosis antagonist
0,660  0,005  Tumour necrosis factor alpha release inhibitor
0,655  0,003  Hemostatic
0,649  0,006  DNA damaging
0,642  0,005  Antihelmintic
0,635  0,003  Antidote
0,640  0,008  Caspase 3 stimulant
0,634  0,004  Non-steroidal antiinflammatory agent
0,630  0,002  Cyclooxygenase 3 inhibitor
0,628  0,007  Antipyretic
0,624  0,007  Amyloid beta aggregation inhibitor
0,614  0,010  Antipruritic, allergic
0,603  0,003  Alkaline phosphatase inhibitor
0,610  0,023  Antileukemic
0,587  0,002  Nitric-oxide synthase stimulant
0,597  0,012  Cytotoxic
0,580  0,003  AMP-activated protein kinase stimulant
0,610  0,033  Antineoplastic (breast cancer)
0,590  0,014  Analeptic
0,577  0,004  Lipid peroxidase inhibitor
0,576  0,004  ICAM1 expression inhibitor
0,600  0,030  Antineoplastic (lung cancer)
0,579  0,009  Antiprotozoal (Leishmania)
0,587  0,018  Immunostimulant
0,568  0,005  Topoisomerase II inhibitor
0,568  0,008  Antineoplastic (osteosarcoma)
0,563  0,008  Vasodilator
0,559  0,004  DNA methyltransferase I inhibitor
0,556  0,004  Antitussive
0,560  0,014  Antiosteoporotic
0,551  0,005  UGT2B4 substrate
0,563  0,018  CYP2C19 substrate
0,559  0,018  Stroke treatment
0,542  0,003  Protein kinase stimulant
0,552  0,014  Antifungal
0,556  0,019  Bone diseases treatment
0,559  0,023  Prostate cancer treatment
0,546  0,014  Antiischemic
0,535  0,005  DNA methylase inhibitor
0,525  0,004  UGT2B15 substrate
0,523  0,009  Myocardial infarction treatment
0,536  0,024  Immunosuppressant
0,510  0,007  Radiosensitizer
0,504  0,003  Carbonic anhydrase III inhibitor
0,534  0,038  Alzheimer's disease treatment
0,502  0,007  UGT1A3 substrate
0,502  0,011  RNA-directed DNA polymerase inhibitor
0,522  0,032  Antineoplastic (colorectal cancer)
0,508  0,022  Sensitization
0,490  0,005  Glutathione S-transferase substrate
0,485  0,005  VCAM1 expression inhibitor
0,488  0,011  Peroxidase inhibitor
0,499  0,027  Antineoplastic (ovarian cancer)
0,476  0,006  Platelet adhesion inhibitor
0,470  0,003  Alcohol dehydrogenase inhibitor
0,467  0,004  Interleukin 4 antagonist
0,464  0,004  Mediator release inhibitor
0,471  0,012  Antineoplastic (liver cancer)
0,471  0,015  Antidiabetic symptomatic
0,480  0,025  Antineoplastic (cervical cancer)
0,463  0,009  Cyclic AMP phosphodiesterase inhibitor
0,456  0,004  Topoisomerase II alpha inhibitor
0,476  0,027  CYP1A2 substrate
0,502  0,055  Antiarthritic
0,465  0,025  Antineoplastic (glioma)
0,448  0,015  Antineoplastic enhancer
0,437  0,004  Expectorant
0,467  0,038  Antineoplastic (colon cancer)
0,429  0,003  Creatine kinase inhibitor
0,437  0,012  Antineoplastic (sarcoma)
0,430  0,006  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,448  0,028  Antineoplastic (pancreatic cancer)
0,419  0,007  Alkylator
0,420  0,009  Antiviral (Influenza)
0,412  0,002  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,409  0,006  Antidiarrheal
0,433  0,031  Antineoplastic (brain cancer)
0,435  0,035  Immunomodulator
0,402  0,005  Psychosexual dysfunction treatment
0,420  0,024  Antineoplastic (glioblastoma multiforme)
0,396  0,005  Dementia treatment
0,394  0,003  Antiviral (Ebola)
0,409  0,018  Antiulcerative
0,393  0,003  Antihelmintic (Trematoda)
0,393  0,005  Vascular dementia treatment
0,392  0,004  Carbonic anhydrase VI inhibitor
0,419  0,034  Lipoprotein disorders treatment
0,382  0,003  Antiviral (Influenza B)
0,430  0,053  Atherosclerosis treatment
0,386  0,008  Peptidyltransferase inhibitor
0,380  0,006  Topoisomerase I inhibitor
0,388  0,015  Antiviral (Herpes)
0,390  0,017  P-glycoprotein inhibitor
0,376  0,004  Choleretic
0,376  0,013  Antipruritic, non-allergic
0,402  0,040  Antineoplastic (melanoma)
0,393  0,033  Antidiabetic (type 2)
0,364  0,005  Gout treatment
0,373  0,015  Diuretic
0,392  0,033  Antineoplastic (multiple myeloma)
0,361  0,004  Aldose reductase inhibitor
0,386  0,032  Interleukin 2 agonist
0,366  0,015  Thrombolytic
0,354  0,004  Selectin antagonist
0,358  0,008  Neurotrophic factor enhancer
0,394  0,051  Cholesterol antagonist
0,356  0,014  Interferon gamma antagonist
0,344  0,004  DNA repair enzyme inhibitor
0,340  0,004  Photosensitizer
0,357  0,029  DNA synthesis inhibitor
0,337  0,009  Insulin secretagoues
0,332  0,008  Antineoplastic antibiotic
0,347  0,026  Wound healing agent
0,334  0,014  Protein-tyrosine phosphatase inhibitor
0,326  0,008  Aldose reductase substrate
0,332  0,017  Antineoplastic (squamous cell carcinoma)
0,317  0,005  Anticataract
0,346  0,035  Pyruvate kinase inhibitor
0,348  0,039  Platelet antagonist
0,315  0,009  Hexokinase inhibitor
0,348  0,044  Antineoplastic (non-small cell lung cancer)
0,307  0,004  Carbonic anhydrase XIV inhibitor
0,340  0,040  Antineoplastic (small cell lung cancer)
0,310  0,009  Cell wall synthesis inhibitor
0,310  0,011  Aldehyde dehydrogenase inhibitor
0,306  0,020  Carcinogenic, group 3
0,283  0,005  Uric acid excretion stimulant
0,288  0,011  Antifungal enhancer
0,280  0,004  Carbonic anhydrase VII inhibitor
0,281  0,005  Carbonic anhydrase XII inhibitor
0,281  0,004  Histone deacetylase SIRT1 stimulant
0,281  0,004  Histone deacetylase stimulant
0,338  0,062  CYP2D6 substrate
0,289  0,014  Acute respiratory distress syndrome (ARDS) treatment
0,278  0,004  Multidrug resistance-associated protein 1 inhibitor
0,274  0,004  Heat shock protein 70 antagonist
0,281  0,012  Protein-tyrosine phosphatase 1B inhibitor
0,293  0,028  UGT2B7 substrate
0,274  0,009  ATPase inhibitor
0,267  0,004  Interleukin 12 antagonist
0,309  0,048  Antineoplastic (lymphoma)
0,274  0,020  Antiviral (Influenza A)
0,259  0,009  Antibiotic
0,297  0,053  Antineoplastic (renal cancer)
0,259  0,015  Chelator
0,283  0,040  Septic shock treatment
0,249  0,006  Estrogen agonist
0,248  0,008  Arylamine N-Acetyltransferase substrate
0,254  0,015  SULT1A3 substrate
0,290  0,052  Hypolipemic
0,337  0,099  Antiprotozoal
0,296  0,062  Huntington's disease treatment
0,244  0,011  Retinoprotector
0,294  0,061  CYP1A2 inhibitor
0,245  0,014  UDP-glucose 4-epimerase inhibitor
0,235  0,007  Gastritis treatment
0,231  0,004  Xanthine dehydrogenase inhibitor
0,228  0,004  Fatty acid synthase inhibitor
0,221  0,003  Antibiotic Glycopeptide-like
0,284  0,066  Aryl hydrocarbon receptor agonist
0,250  0,034  Sepsis treatment
0,228  0,015  Antirickettsial
0,241  0,028  Cyclooxygenase inhibitor
0,247  0,036  Insulin sensitizer
0,208  0,002  Arginase inhibitor
0,213  0,009  HIV-1 integrase (3'-Processing) inhibitor
0,217  0,015  Antifungal (Cryptococcus)
0,219  0,021  Mannose-6-phosphate isomerase inhibitor
0,207  0,009  HIV-1 integrase (Strand Transfer) inhibitor
0,293  0,095  Antiallergic
0,308  0,111  GABA C receptor rho-3 antagonist
0,225  0,029  Interleukin 6 antagonist
0,221  0,025  Carcinogenic, group 1
0,228  0,033  Liver fibrosis treatment
0,219  0,029  Alpha-N-acetylglucosaminidase inhibitor
0,209  0,022  Cell adhesion inhibitor
0,263  0,077  Aldehyde oxidase inhibitor
0,221  0,038  Antineoplastic (carcinoma)
0,211  0,028  Cyclooxygenase 2 inhibitor
0,212  0,030  Acetylcholinesterase inhibitor
0,208  0,026  DNA polymerase I inhibitor
0,271  0,090  Metabolic disease treatment
0,198  0,017  Growth stimulant
0,188  0,008  Toll-Like receptor 4 antagonist
0,188  0,009  Thioredoxin inhibitor
0,194  0,017  UGT2B1 substrate
0,200  0,026  DNA intercalator
0,239  0,066  Interleukin antagonist
0,177  0,005  Neuraminidase (influenza) inhibitor
0,177  0,008  T cell inhibitor
0,210  0,043  VEGF expression inhibitor
0,183  0,016  Antispirochetal
0,181  0,015  Estrogen antagonist
0,246  0,081  Interleukin agonist
0,175  0,016  Chronic obstructive bronchitis treatment
0,172  0,014  NADH dehydrogenase inhibitor
0,162  0,005  Narcotic antagonist
0,299  0,142  Antiparkinsonian
0,170  0,014  NAD(P)H dehydrogenase (quinone) inhibitor
0,193  0,037  Cyclooxygenase 1 inhibitor
0,157  0,002  Cholesterol absorption inhibitor
0,158  0,006  Estrogen receptor beta agonist
0,161  0,013  SULT1E1 substrate
0,192  0,046  Antineoplastic (bone cancer)
0,202  0,056  Diabetic nephropathy treatment
0,149  0,006  Neuraminidase inhibitor
0,185  0,048  Contraceptive
0,194  0,056  Antineoplastic (gastric cancer)
0,164  0,029  SULT1A1 substrate
0,254  0,120  Angiogenesis inhibitor
0,161  0,026  Falcipain inhibitor
0,183  0,049  UGT2B9 substrate
0,158  0,025  Falcipain 2 inhibitor
0,159  0,027  Antineoplastic (uterine cancer)
0,174  0,042  M18 aspartyl aminopeptidase inhibitor
0,144  0,013  Restless leg syndrome treatment
0,206  0,076  Psychostimulant
0,156  0,027  HDL-cholesterol increasing
0,228  0,101  5 Hydroxytryptamine release stimulant
0,148  0,021  Triose-phosphate isomerase inhibitor
0,136  0,009  Na+ K+ transporting ATPase inhibitor
0,185  0,059  Anticoagulant
0,136  0,013  Postmenopausal disorders treatment
0,177  0,057  Neuropathy treatment
0,127  0,006  Antimycoplasmal
0,185  0,065  UGT1A4 substrate
0,150  0,032  Mucolytic
0,122  0,004  Glucose-6-phosphate translocase inhibitor
0,164  0,049  Bone formation stimulant
0,208  0,093  Antineoplastic (lymphocytic leukemia)
0,131  0,017  Phosphodiesterase 6D inhibitor
0,130  0,018  Interleukin 5 antagonist
0,132  0,020  Transcription factor NF kappa B stimulant
0,147  0,036  Antischistosomal
0,164  0,054  CF transmembrane conductance regulator agonist
0,138  0,029  Breast cancer-resistant protein inhibitor
0,130  0,022  Phosphofructokinase-1 inhibitor
0,125  0,018  CDC25A inhibitor
0,129  0,024  Estrogen receptor beta antagonist
0,115  0,012  Maillard reaction inhibitor
0,133  0,032  DOPA decarboxylase inhibitor
0,119  0,020  ATPase (Vacuolar H+) inhibitor
0,107  0,009  Leukotriene B4 antagonist
0,139  0,042  CC chemokine 6 receptor antagonist
0,169  0,074  Phospholipase C inhibitor
0,111  0,019  HIV-1 integrase inhibitor
0,211  0,119  Antineoplastic (bladder cancer)
0,130  0,039  Antineoplastic, alkylator
0,094  0,004  Heparanase inhibitor
0,222  0,132  Antimycobacterial
0,140  0,052  Antiviral (Hepatitis B)
0,116  0,028  Antiviral (Trachoma)
0,105  0,017  Phosphodiesterase VI inhibitor
0,189  0,104  Antiviral (HIV)
0,109  0,023  Lipase inhibitor
0,089  0,003  Sodium/glucose cotransporter 2 inhibitor
0,098  0,013  Protein 50S ribosomal subunit inhibitor
0,093  0,010  Topoisomerase II beta inhibitor
0,106  0,023  D-Ala-D-Ala ligase inhibitor
0,148  0,069  Antiprotozoal (Coccidial)
0,133  0,055  Cholesterol synthesis inhibitor
0,128  0,052  Microtubule formation inhibitor
0,118  0,043  Antifibrinolytic
0,101  0,027  Carbonic anhydrase inhibitor
0,076  0,004  Sodium/glucose cotransporter inhibitor
0,075  0,005  Antibiotic Aminoglycoside-like
0,194  0,124  Superoxide dismutase inhibitor
0,219  0,152  GST M1-1 substrate
0,155  0,088  Dual specificity phosphatase inhibitor
0,139  0,073  Ribosomal protein S6 kinase inhibitor
0,099  0,034  Telomerase inhibitor
0,096  0,031  Antiviral (Dengue virus)
0,069  0,005  Protein 30S ribosomal subunit inhibitor
0,089  0,025  Antitreponemal
0,085  0,022  Antidote, heavy metal
0,070  0,007  Neuraminidase (Influenza A) inhibitor
0,114  0,052  Carbonic anhydrase XV inhibitor
0,144  0,082  GABA C receptor rho-2 antagonist
0,149  0,088  Antihelmintic (Nematodes)
0,084  0,024  DNA gyrase inhibitor
0,126  0,067  Papain-like protease (SARS coronavirus) inhibitor
0,081  0,022  Nitric oxide donor
0,138  0,080  Ca2+-transporting ATPase inhibitor
0,114  0,058  Carcinogenic, group 2B
0,148  0,093  Muscular dystrophy treatment
0,132  0,081  Hair growth stimulant
0,126  0,076  Antiacne
0,137  0,088  Cholinergic
0,195  0,146  Lipoxygenase inhibitor
0,097  0,048  Ornithine decarboxylase inhibitor
0,147  0,099  Dual specificity phosphatase 3 inhibitor
0,077  0,030  CDC25B inhibitor
0,084  0,040  Histidine decarboxylase inhibitor
0,266  0,222  Antineoplastic (solid tumors)
0,067  0,024  Lipocortins synthesis agonist
0,064  0,022  Adenine nucleotide translocase inhibitor
0,076  0,035  Leukotriene antagonist
0,208  0,167  Vasodilator, peripheral
0,141  0,100  Cystic fibrosis treatment
0,056  0,016  Estrogen receptor alpha agonist
0,147  0,107  Sedative
0,086  0,048  Thioredoxin reductase inhibitor
0,058  0,020  Glucose-6-phosphate isomerase inhibitor
0,069  0,033  Carbonic anhydrase IX inhibitor
0,068  0,033  Transcription factor AP-1 inhibitor
0,040  0,005  Sodium/glucose cotransporter 1 inhibitor
0,091  0,058  Actinic keratosis treatment
0,212  0,183  Inflammatory Bowel disease treatment
0,035  0,007  Dopamine D1 agonist
0,054  0,026  Factor III inhibitor
0,231  0,204  DNA directed DNA polymerase inhibitor
0,113  0,086  Toll-Like receptor 2 antagonist
0,112  0,085  Antifungal (Pneumocystis)
0,107  0,081  Beta amyloid protein antagonist
0,153  0,128  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,029  0,004  Antibiotic Anthracycline-like
0,093  0,069  UGT2B11 substrate
0,056  0,033  Alpha-mannosidase inhibitor
0,031  0,009  Vanilloid 2 agonist
0,050  0,030  Adenosine deaminase inhibitor
0,036  0,016  Estrogen-related receptor beta antagonist
0,110  0,090  Tubulin antagonist
0,029  0,013  Toll-Like receptor 4 agonist
0,046  0,030  Mannosidase inhibitor
0,181  0,166  Transcription factor STAT inhibitor
0,030  0,015  1,3-Beta-glucan synthase inhibitor
0,073  0,060  Estrogen receptor alpha antagonist
0,124  0,111  Phospholipase A2 inhibitor
0,024  0,013  Leukotriene B4 receptor 2 antagonist
0,125  0,114  Adenylate cyclase stimulant
0,044  0,035  Microtubule stabilization
0,070  0,061  SULT1A2 substrate
0,084  0,076  MAO A inhibitor
0,032  0,024  Catechol O-methyltransferase inhibitor
0,165  0,158  Antiprotozoal (Trypanosoma)
0,050  0,043  Protein kinase C eta inhibitor
0,103  0,097  Transcription factor STAT6 inhibitor
0,139  0,134  Antiviral (Hepatitis)
0,097  0,093  TRPA1 agonist
0,016  0,013  Telomerase stimulant
0,046  0,044  Factor IXa inhibitor

